
Epidermolysis Bullosa: Future Perspectives In Drug Development
Epidermolysis bullosa (EB) is a heterogeneous group of rare genetic disorders marked by skin and mucosal fragility, presenting significant challenges in management and treatment. Current therapeutic approaches remain largely symptomatic, focusing on wound …